NCT02346890View on ClinicalTrials.gov

A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Healthy

Interventions

DRUG

AZD1722

DRUG

Renvela

Trial Locations (1)

78209

Healthcare Discoveries, LLC, San Antonio

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Ardelyx

INDUSTRY